Ken Kato

Associations of Plasma Concentration Profiles of Dapagliflozin, a Selective Inhibitor of Sodium–Glucose Co-Transporter Type 2, with Its Effects in Japanese Patients with Type 2 Diabetes Mellitus

T. Hayakawa, T. Sakaeda, S. Kobuchi, 2022, Pharmaceuticals.

Improvement by Thiazolidinediones of Vascular Endothelial Cell Dysfunction in Diabetic Patients: A Possible New Physiological Role of PPARγ

H. Satoh, S. Midorikawa, Tsuyoshi Watanabe, 2000 .

Mmol/l at 95% Confidence from Commonly Estimated a Nondiabetic Case of Hemoglobin Variant (hb Ni- Igata) with Inappropriately High and Low Hba1c Titers Detected by Different Methods, Tsuyoshi Watanabe, 1*

S. Midorikawa, Tsuyoshi Watanabe, M. Miura, 1998 .

Thiazolidinediones down-regulate plasminogen activator inhibitor type 1 expression in human vascular endothelial cells: A possible role for PPARgamma in endothelial function.

T. Watanabe, T. Fujita, Y. Endo, 1999, Biochemical and biophysical research communications.

Improvement by the insulin-sensitizing agent, troglitazone, of abnormal fibrinolysis in type 2 diabetes mellitus.

S. Midorikawa, W. Sato, D. Yamada, 2000, Metabolism: clinical and experimental.

A nondiabetic case of hemoglobin variant (Hb Niigata) with inappropriately high and low HbA1c titers detected by different methods.

S. Midorikawa, M. Miura, W. Sato, 1998, Clinical chemistry.

Acetonation of linear (1?3)--?-glucan

Ken Kato, 1982 .